Chapters

Transcript

Video

Rebecca Porter, MD, PhD Discusses Endometrial Cancer Research at AACR24

Dana-Farber's Rebecca Porter, MD, PhD, says antibody-drug conjugate combined with immunotherapy had impressive overall response rate in 16 patients with a rare subtype, but more research is needed.


Published

April 10, 2024

Created by

Dana-Farber

Related Presenters

Rebecca L. Porter, MD, PhD

Rebecca L. Porter, MD, PhD

Medical Oncology

Rebecca Porter, MD, PhD is a Medical Oncologist and an active translational and clinical researcher in the Gynecologic Oncology Program in the Dana-Farber Cancer Institute's Susan F. Smith Center for Women's Cancers. Dr. Porter received ...

View full profile